Cargando…
A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM: A case report
The widespread adoption of gene panel testing for cancer predisposition is leading to the identification of an increasing number of individuals with clinically relevant allelic variants in two or more genes. The potential combined effect of these variants on cancer risks is mostly unknown, posing a...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072264/ https://www.ncbi.nlm.nih.gov/pubmed/37025588 http://dx.doi.org/10.3389/fonc.2023.1102184 |
_version_ | 1785019347000885248 |
---|---|
author | Colombo, Mara Mondini, Patrizia Minenza, Elisa Foglia, Claudia Mosconi, Annamaria Molica, Carmen Pistola, Lorenza Ludovini, Vienna Radice, Paolo |
author_facet | Colombo, Mara Mondini, Patrizia Minenza, Elisa Foglia, Claudia Mosconi, Annamaria Molica, Carmen Pistola, Lorenza Ludovini, Vienna Radice, Paolo |
author_sort | Colombo, Mara |
collection | PubMed |
description | The widespread adoption of gene panel testing for cancer predisposition is leading to the identification of an increasing number of individuals with clinically relevant allelic variants in two or more genes. The potential combined effect of these variants on cancer risks is mostly unknown, posing a serious problem for genetic counseling in these individuals and their relatives, in whom the variants may segregate singly or in combination. We report a female patient who developed triple-negative high grade carcinoma in the right breast at the age of 36 years. The patient underwent bilateral mastectomy followed by combined immunotherapy and chemotherapy (IMpassion030 clinical trial). Two years later she developed a skin recurrence on the right anterior chest wall. Despite intensive treatment, the patient died at 40-year-old due to disease progression. Gene panel testing of patient’s DNA revealed the presence of a protein truncating variant in ATM [c.1672G>T; p.(Gly558Ter)] and of a not previously reported variant in the BRCA1 exon 22 donor splice site [c.5406+6T>G], whose clinical significance was unknown. The analysis of patient’s RNA revealed the up-regulation of two alternative BRCA1 mRNA isoforms derived from skipping of exon 22 and of exons 22-23. The corresponding predicted protein products, p.(Asp1778GlyfsTer27) and p.(Asp1778_His1822del) are both expected to affect the BRCA1 C Terminus (BRCT) domain. The two variants were observed to co-occur also in the proband’s brother who, in addition, was heterozygous for a common variant (c.4837A>G) mapped to BRCA1 exon 16. This allowed to ascertain, by transcript-specific amplification, the lack of functional mRNA isoforms expressed by the c.5406+6T>G allele and provided evidence to classify the BRCA1 variant as pathogenic, according to the guidelines of the Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) consortium. To our knowledge, excluding two cases detected following the screening of population specific recurrent variants, only one ATM/BRCA1 double heterozygote has been reported in the literature, being the case here described the one with the youngest age at cancer onset. The systematic collection of cases with pathogenic variants in more than one cancer predisposition gene is needed to verify if they deserve ad hoc counseling and clinical management. |
format | Online Article Text |
id | pubmed-10072264 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100722642023-04-05 A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM: A case report Colombo, Mara Mondini, Patrizia Minenza, Elisa Foglia, Claudia Mosconi, Annamaria Molica, Carmen Pistola, Lorenza Ludovini, Vienna Radice, Paolo Front Oncol Oncology The widespread adoption of gene panel testing for cancer predisposition is leading to the identification of an increasing number of individuals with clinically relevant allelic variants in two or more genes. The potential combined effect of these variants on cancer risks is mostly unknown, posing a serious problem for genetic counseling in these individuals and their relatives, in whom the variants may segregate singly or in combination. We report a female patient who developed triple-negative high grade carcinoma in the right breast at the age of 36 years. The patient underwent bilateral mastectomy followed by combined immunotherapy and chemotherapy (IMpassion030 clinical trial). Two years later she developed a skin recurrence on the right anterior chest wall. Despite intensive treatment, the patient died at 40-year-old due to disease progression. Gene panel testing of patient’s DNA revealed the presence of a protein truncating variant in ATM [c.1672G>T; p.(Gly558Ter)] and of a not previously reported variant in the BRCA1 exon 22 donor splice site [c.5406+6T>G], whose clinical significance was unknown. The analysis of patient’s RNA revealed the up-regulation of two alternative BRCA1 mRNA isoforms derived from skipping of exon 22 and of exons 22-23. The corresponding predicted protein products, p.(Asp1778GlyfsTer27) and p.(Asp1778_His1822del) are both expected to affect the BRCA1 C Terminus (BRCT) domain. The two variants were observed to co-occur also in the proband’s brother who, in addition, was heterozygous for a common variant (c.4837A>G) mapped to BRCA1 exon 16. This allowed to ascertain, by transcript-specific amplification, the lack of functional mRNA isoforms expressed by the c.5406+6T>G allele and provided evidence to classify the BRCA1 variant as pathogenic, according to the guidelines of the Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) consortium. To our knowledge, excluding two cases detected following the screening of population specific recurrent variants, only one ATM/BRCA1 double heterozygote has been reported in the literature, being the case here described the one with the youngest age at cancer onset. The systematic collection of cases with pathogenic variants in more than one cancer predisposition gene is needed to verify if they deserve ad hoc counseling and clinical management. Frontiers Media S.A. 2023-03-21 /pmc/articles/PMC10072264/ /pubmed/37025588 http://dx.doi.org/10.3389/fonc.2023.1102184 Text en Copyright © 2023 Colombo, Mondini, Minenza, Foglia, Mosconi, Molica, Pistola, Ludovini and Radice https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Colombo, Mara Mondini, Patrizia Minenza, Elisa Foglia, Claudia Mosconi, Annamaria Molica, Carmen Pistola, Lorenza Ludovini, Vienna Radice, Paolo A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM: A case report |
title | A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM: A case report |
title_full | A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM: A case report |
title_fullStr | A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM: A case report |
title_full_unstemmed | A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM: A case report |
title_short | A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM: A case report |
title_sort | novel brca1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in atm: a case report |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072264/ https://www.ncbi.nlm.nih.gov/pubmed/37025588 http://dx.doi.org/10.3389/fonc.2023.1102184 |
work_keys_str_mv | AT colombomara anovelbrca1splicingvariantdetectedinanearlyonsettriplenegativebreastcancerpatientadditionallycarryingapathogenicvariantinatmacasereport AT mondinipatrizia anovelbrca1splicingvariantdetectedinanearlyonsettriplenegativebreastcancerpatientadditionallycarryingapathogenicvariantinatmacasereport AT minenzaelisa anovelbrca1splicingvariantdetectedinanearlyonsettriplenegativebreastcancerpatientadditionallycarryingapathogenicvariantinatmacasereport AT fogliaclaudia anovelbrca1splicingvariantdetectedinanearlyonsettriplenegativebreastcancerpatientadditionallycarryingapathogenicvariantinatmacasereport AT mosconiannamaria anovelbrca1splicingvariantdetectedinanearlyonsettriplenegativebreastcancerpatientadditionallycarryingapathogenicvariantinatmacasereport AT molicacarmen anovelbrca1splicingvariantdetectedinanearlyonsettriplenegativebreastcancerpatientadditionallycarryingapathogenicvariantinatmacasereport AT pistolalorenza anovelbrca1splicingvariantdetectedinanearlyonsettriplenegativebreastcancerpatientadditionallycarryingapathogenicvariantinatmacasereport AT ludovinivienna anovelbrca1splicingvariantdetectedinanearlyonsettriplenegativebreastcancerpatientadditionallycarryingapathogenicvariantinatmacasereport AT radicepaolo anovelbrca1splicingvariantdetectedinanearlyonsettriplenegativebreastcancerpatientadditionallycarryingapathogenicvariantinatmacasereport AT colombomara novelbrca1splicingvariantdetectedinanearlyonsettriplenegativebreastcancerpatientadditionallycarryingapathogenicvariantinatmacasereport AT mondinipatrizia novelbrca1splicingvariantdetectedinanearlyonsettriplenegativebreastcancerpatientadditionallycarryingapathogenicvariantinatmacasereport AT minenzaelisa novelbrca1splicingvariantdetectedinanearlyonsettriplenegativebreastcancerpatientadditionallycarryingapathogenicvariantinatmacasereport AT fogliaclaudia novelbrca1splicingvariantdetectedinanearlyonsettriplenegativebreastcancerpatientadditionallycarryingapathogenicvariantinatmacasereport AT mosconiannamaria novelbrca1splicingvariantdetectedinanearlyonsettriplenegativebreastcancerpatientadditionallycarryingapathogenicvariantinatmacasereport AT molicacarmen novelbrca1splicingvariantdetectedinanearlyonsettriplenegativebreastcancerpatientadditionallycarryingapathogenicvariantinatmacasereport AT pistolalorenza novelbrca1splicingvariantdetectedinanearlyonsettriplenegativebreastcancerpatientadditionallycarryingapathogenicvariantinatmacasereport AT ludovinivienna novelbrca1splicingvariantdetectedinanearlyonsettriplenegativebreastcancerpatientadditionallycarryingapathogenicvariantinatmacasereport AT radicepaolo novelbrca1splicingvariantdetectedinanearlyonsettriplenegativebreastcancerpatientadditionallycarryingapathogenicvariantinatmacasereport |